Oryzon Genomics (Spain) Probability of Future Stock Price Finishing Under 0.04
| ORY Stock | EUR 1.56 0.01 0.64% |
Oryzon |
Oryzon Genomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oryzon Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oryzon Genomics SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oryzon Genomics SA generated a negative expected return over the last 90 days | |
| Oryzon Genomics SA may become a speculative penny stock | |
| Net Loss for the year was (4.69 M) with profit before overhead, payroll, taxes, and interest of 9.87 M. | |
| Oryzon Genomics SA has accumulated about 29.11 M in cash with (3.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders |
Oryzon Genomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oryzon Stock often depends not only on the future outlook of the current and potential Oryzon Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oryzon Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.8 M |
Oryzon Genomics Technical Analysis
Oryzon Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. Oryzon Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oryzon Genomics SA. In general, you should focus on analyzing Oryzon Stock price patterns and their correlations with different microeconomic environments and drivers.
Oryzon Genomics Predictive Forecast Models
Oryzon Genomics' time-series forecasting models is one of many Oryzon Genomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oryzon Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Oryzon Genomics SA
Checking the ongoing alerts about Oryzon Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oryzon Genomics SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oryzon Genomics SA generated a negative expected return over the last 90 days | |
| Oryzon Genomics SA may become a speculative penny stock | |
| Net Loss for the year was (4.69 M) with profit before overhead, payroll, taxes, and interest of 9.87 M. | |
| Oryzon Genomics SA has accumulated about 29.11 M in cash with (3.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Oryzon Stock
Oryzon Genomics financial ratios help investors to determine whether Oryzon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oryzon with respect to the benefits of owning Oryzon Genomics security.